作者: Robert Michael Hughes , Benjamin Joseph Littler , Elaine Chungmin Lee , David Andrew Siesel , Cristian Harrison
DOI:
关键词:
摘要: The present invention features processes for preparing compounds, such as (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2- (1 -hydroxy-2-methylpropan-2-yl)- 1H-indol-5 -yl)cyclopropanecarboxamide (Compound 1 ), useful treating CFTR mediated diseases cystic fibrosis.